LENZ THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
LENZ THERAPEUTICS, INC. (LENZ) reported Increase (Decrease) in Prepaid Expense and Other Assets of $2.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-11
- LENZ THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $2.58M, a 1187.50% increase year-over-year.
- LENZ THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $341.00K, a 65.76% decline year-over-year.
- LENZ THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $1.92M.
- LENZ THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$93.00K, a 132.63% decline year-over-year.
- LENZ THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $3.03M.
- LENZ THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$25.00K.
- LENZ THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$761.00K, a 123.70% decline from fiscal 2022.
- LENZ THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $3.21M, a 17.96% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $2.92M 10-Q · filed 2026-08-11 | $4.84M derived: sum of 3 quarters · filed 2026-08-11 | $4.75M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $341.00K 10-Q · filed 2026-05-11 | $2.27M derived: sum of 2 quarters · filed 2026-05-11 | $2.17M derived: sum of 3 quarters · filed 2026-05-11 | $2.37M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $1.83M derived: sum of 2 quarters · filed 2026-03-24 | $2.03M derived: sum of 3 quarters · filed 2026-08-11 | $3.03M 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | -$93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $107.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.10M 10-Q · filed 2025-11-05 | $394.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.20M 10-Q · filed 2026-08-11 | $487.00K derived: sum of 3 quarters · filed 2026-08-11 | $772.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $996.00K 10-Q · filed 2026-05-11 | $287.00K derived: sum of 2 quarters · filed 2026-05-11 | $572.00K derived: sum of 3 quarters · filed 2026-05-11 | $453.00K derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$709.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$424.00K derived: sum of 2 quarters · filed 2026-03-24 | -$543.00K derived: sum of 3 quarters · filed 2026-03-24 | -$25.00K 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | $285.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $166.00K derived: sum of 2 quarters · filed 2025-11-05 | $684.00K 10-Q · filed 2025-11-05 | $408.00K derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | -$119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $399.00K 10-Q · filed 2025-07-30 | $123.00K derived: sum of 3 quarters · filed 2025-07-30 | -$287.00K derived: sum of 4 quarters · filed 2025-07-30 | ||||
| 2024-03-31 | $518.00K 10-Q · filed 2025-05-07 | $242.00K derived: sum of 2 quarters · filed 2025-05-07 | -$168.00K derived: sum of 3 quarters · filed 2025-05-07 | $183.00K derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | -$276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$686.00K derived: sum of 2 quarters · filed 2025-03-19 | -$335.00K derived: sum of 3 quarters · filed 2025-03-19 | -$761.00K 10-K · filed 2025-03-19 | -$5.68M 10-K · filed 2024-02-27 | |||
| 2023-09-30 | -$410.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$59.00K derived: sum of 2 quarters · filed 2024-11-06 | -$485.00K 10-Q · filed 2024-11-06 | -$4.88M 10-Q · filed 2023-11-13 | $289.00K derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | $351.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$75.00K 10-Q · filed 2024-08-14 | -$7.11M 10-Q · filed 2023-08-14 | $699.00K derived: sum of 3 quarters · filed 2024-08-14 | $3.66M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$426.00K 10-Q · filed 2024-05-08 | -$1.46M 10-Q · filed 2023-05-11 | $348.00K derived: sum of 2 quarters · filed 2024-05-08 | $3.31M derived: sum of 3 quarters · filed 2024-05-08 | $2.71M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | $774.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $3.74M derived: sum of 2 quarters · filed 2024-02-27 | $3.14M derived: sum of 3 quarters · filed 2024-02-27 | $3.21M 10-K · filed 2024-02-27 | ||||
| 2022-09-30 | $2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.37M derived: sum of 2 quarters · filed 2023-11-13 | $2.44M 10-Q · filed 2023-11-13 | $1.35M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$598.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$527.00K 10-Q · filed 2023-08-14 | -$1.61M derived: sum of 3 quarters · filed 2023-08-14 | $2.02M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $71.00K 10-Q · filed 2023-05-11 | -$1.02M derived: sum of 2 quarters · filed 2023-05-11 | $2.62M derived: sum of 3 quarters · filed 2023-05-11 | $2.17M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $2.55M derived: sum of 2 quarters · filed 2023-03-20 | $2.10M derived: sum of 3 quarters · filed 2023-03-20 | $3.91M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $3.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.19M derived: sum of 2 quarters · filed 2022-11-09 | $5.00M 10-Q · filed 2022-11-09 | $6.03M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$453.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.36M 10-Q · filed 2022-08-11 | $2.39M derived: sum of 3 quarters · filed 2022-08-11 | $2.29M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $1.82M 10-Q · filed 2022-05-12 | $2.85M derived: sum of 2 quarters · filed 2022-05-12 | $2.74M derived: sum of 3 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $925.00K derived: sum of 2 quarters · filed 2022-03-21 | $1.29M 10-K · filed 2022-03-21 | |||||
| 2020-09-30 | -$104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $257.00K 10-Q · filed 2021-11-10 | ||||||
| 2020-06-30 | $361.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |